The use of non-TNF targeted biologics in Behçet’s Disease: Real-life data from the International AIDA Network Behçet’s Disease Registry
Abstract Objectives Refractory manifestations of Behçet’s disease (BD) are commonly treated with TNF-α inhibitors; however, a subset of patients do not respond or are intolerant, prompting the need for alternative therapies. This study aimed to assess the real-life use, efficacy…